Zaloguj się

Gotowe bibliografie tematyczne / Mitochondrial diseases / Książki

Książki na temat „Mitochondrial diseases”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Mitochondrial diseases.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 9 marca 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Mitochondrial diseases”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

James, Holt Ian, red. Genetics of mitochondrial diseases. Oxford: Oxford University Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Navas, Placido, i Leonardo Salviati, red. Mitochondrial Diseases. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-70147-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Lestienne, Patrick, red. Mitochondrial Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59884-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

service), ScienceDirect (Online, red. Mitochondrial function: Mitochondrial protein kinases, protein phosphatases and mitochondrial diseases. San Diego, Calif: Academic Press/Elsevier, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

N, Gellerich Frank, Zierz S i Colloquium on Mitochondria and Myopathies (1st : 1995 : Halle an der Saale, Germany), red. Detection of mitochondrial diseases. Dordrecht: Kluwer Academic, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Sun, Hongzhi, i Xiangdong Wang, red. Mitochondrial DNA and Diseases. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-6674-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Gellerich, Frank Norbert, i Stephan Zierz, red. Detection of Mitochondrial Diseases. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-6111-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Anna, Gvozdjáková, red. Mitochondrial medicine: Mitochondrial metabolism, diseases, diagnosis and therapy. Dordrecht: Springer, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

V, Schapira Anthony H., i DiMauro S, red. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

S, DiMauro, Hirano Michio i Schon Eric A, red. Mitochondrial medicine. Abingdon [U.K.]: Informa Healthcare, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Mitochondrial medicine. New York: Humana Press, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Mitochondrial dysfunction and oxidativedamage in neurodegenerative diseases. New York: Springer, 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

M, Smeitink Jan A., Sengers Rob C. A i Trijbels J. M. Frans, red. Oxidative phosphorylation in health and disease. Georgetown, Tex., U.S.A: Landes Bioscience/Eurekah.com, 2004.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Beal, M. Flint. Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases. Austin: R.G. Landes Co., 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

C, St John Justin, red. The mitochondrion in the germline and early development. San Diego, Calif: Academic Press, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Advances in mitochondrial medicine. Dordrecht: Springer Verlag, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Mitochondrial signaling in health and disease. Boca Raton: Taylor & Francis/CRC Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Reeve, Amy Katherine. Mitochondrial Dysfunction in Neurodegenerative Disorders. London: Springer-Verlag London Limited, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Hidaka, Takuya. Sequence-Specific DNA Binders for the Therapy of Mitochondrial Diseases. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-8436-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

R, Sanberg Paul, Nishino Hitoo i Borlongan Cesario V, red. Mitochondrial inhibitors and neurodegenerative disorders. Totowa, N.J: Humana Press, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Marín-García, José. Mitochondria and their role in cardiovascular disease. New York: Springer, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Mitochondrial Diseases: Models and Methods. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Lestienne, Patrick. Mitochondrial Diseases: Models and Methods. Springer London, Limited, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Lestienne, Patrick. Mitochondrial Diseases: Models and Methods. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Lestienne, Patrick, red. Mitochondrial Diseases: Models and Methods. SPRINGER-VERLAG, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Gorman, Gráinne S., i Patrick F. Chinnery. Mitochondrial diseases. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199658602.003.0011.

Pełny tekst źródła

Streszczenie:

This chapter critiques ten seminal papers that epitomize the advent and evolution of mitochondrial medicine from the latter half of the last century up until today. These important bodies of work span the pre-molecular and molecular eras, from when diagnostic yield was based on meticulous clinical and biochemical characterization of patients, up until now, with targeted next-generation sequencing revolutionizing our diagnostic approach. The first clinical description of a mitochondrial disorder is reviewed and the subsequent landmark papers that define current clinical and molecular understanding of human diseases caused by inherited disorders of mitochondrial dysfunction are chronicled. The chapter also charts the shift in emphasis from diagnosis to the development of treatments and novel approaches for disease prevention.

Style APA, Harvard, Vancouver, ISO itp.

27

Taskin, Eylem, Celal Guven i Yusuf Sevgiler, red. Mitochondrial Diseases. InTech, 2018. http://dx.doi.org/10.5772/67963.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Wiley. Mitochondrial Diseases. Wiley & Sons, Incorporated, John, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Taskin, Eylem, Celal Guven i Yusuf Sevgiler. Mitochondrial Diseases. IntechOpen, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Wiley. Mitochondrial Diseases. Wiley & Sons, Incorporated, John, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Hirano, Michio, Rita Horvath i Patrick Francis Chinnery. Mitochondrial Diseases. Elsevier, 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Horvath, Rita, MIchi Hirano i Patrick Francis Chinnery. Mitochondrial Diseases. Elsevier, 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Berdanier, Carolyn D. Mitochondria in Health and Disease. Taylor & Francis Group, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Mitochondria in health and disease. Boca Raton, Fla: Dekker, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Berdanier, Carolyn D. Mitochondria in Health and Disease. Taylor & Francis Group, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Knott, Andrew B., i Ella Bossy-Wetzel. Mitochondrial Changes and Bioenergetics in Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0012.

Pełny tekst źródła

Streszczenie:

Mitochondria are dynamic organelles that are of critical importance for cellular survival and health. Because mitochondria play central roles in energy production and synaptic maintenance, neurons are believed to be particularly vulnerable to mitochondrial dysfunction. The discovery that genetic mutations in genes coding for mitochondrial proteins cause neurodegenerative conditions further hinted at the likelihood that mitochondrial dysfunction is a key pathway of neurodegeneration. Indeed, a wealth of research has identified mitochondrial dysfunction as an early and shared event of all common neurodegenerative diseases, both genetic and sporadic in origin. Specific types of mitochondrial dysfunction that have been observed in most neurodegenerative diseases include bioenergetic failure, increased oxidative stress, mitochondrial DNA mutations, defective calcium handling, impaired mitochondrial dynamics, defective mitophagy, and decreased mitochondrial biogenesis. The search for drugs that successfully target these pathways of mitochondrial dysfunction in neurodegeneration is ongoing.

Style APA, Harvard, Vancouver, ISO itp.

37

Wang, Xiangdong, i Hongzhi Sun. Mitochondrial DNA and Diseases. Springer, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Mitochondrial Diseases [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.91518.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Detection of Mitochondrial Diseases. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Wang, Xiangdong, i Hongzhi Sun. Mitochondrial DNA and Diseases. Springer, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Mitochondrial DNA and Diseases. Springer, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Gellerich, F. N. Detection of Mitochondrial Diseases. Springer, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Gellerich, F. N., i S. Zierz. Detection of Mitochondrial Diseases. Springer London, Limited, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Mitochondrial function and dysfunction. Amsterdam: Academic Press, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Gvozdjáková, Anna. Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy. Springer, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

(Contributor), S. Di Mauro, red. Mitochondrial Disorders. Springer, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Mitochondrial Function, Part B: Mitochondrial Protein Kinases, Protein Phosphatases and Mitochondrial Diseases. Elsevier, 2009. http://dx.doi.org/10.1016/s0076-6879(09)x0026-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Weissman, Jacqueline, i Lisa Emrick. Diseases of Mitochondrial Energy Metabolism. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0061.

Pełny tekst źródła

Streszczenie:

Mitochondrial disorders are a group of inherited diseases of energy metabolism caused by impairment of mitochondrial function-primarily disorders of the oxidative phosphorylation system but also the more recently described disorders of mitochondrial transport and fission. This review will focus on primary disorders of mitochondrial oxidative phosphorylation. The neurologic system is one of the most profoundly affected by mitochondrial dysfunction and the effects can be varied and widespread. This has led to these diseases being commonly called mitochondrial encephalomyopathies. The heterogeneity of clinical presentation, laboratory findings, neuroimaging findings, pathologic findings, and genetic findings in these diseases make diagnosis extremely difficult. Treatment for mitochondrial disorders is currently lacking a solid evidence base but this is a rapidly expanding area of research.

Style APA, Harvard, Vancouver, ISO itp.

49

Hall, Andrew, i Shamima Rahman. Mitochondrial diseases and the kidney. Redaktor Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0340.

Pełny tekst źródła

Streszczenie:

Mitochondrial disease can affect any organ in the body including the kidney. As increasing numbers of patients with mitochondrial disease are either surviving beyond childhood or being diagnosed in adulthood, it is important for all nephrologists to have some understanding of the common renal complications that can occur in these individuals. Mitochondrial proteins are encoded by either mitochondrial or nuclear DNA (mtDNA and nDNA, respectively); therefore, disease causing mutations may be inherited maternally (mtDNA) or autosomally (nDNA), or can arise spontaneously. The commonest renal phenotype in mitochondrial disease is proximal tubulopathy (Fanconi syndrome in the severest cases); however, as all regions of the nephron can be affected, from the glomerulus to the collecting duct, patients may also present with proteinuria, decreased glomerular filtration rate, nephrotic syndrome, water and electrolyte disorders, and renal tubular acidosis. Understanding of the relationship between underlying genotype and clinical phenotype remains incomplete in mitochondrial disease. Proximal tubulopathy typically occurs in children with severe multisystem disease due to mtDNA deletion or mutations in nDNA affecting mitochondrial function. In contrast, glomerular disease (focal segmental glomerulosclerosis) has been reported more commonly in adults, mainly in association with the m.3243A<G point mutation. Co-enzyme Q10 (CoQ10) deficiency has been particularly associated with podocyte dysfunction and nephrotic syndrome in children. Underlying mitochondrial disease should be considered as a potential cause of unexplained renal dysfunction; clinical clues include lack of response to conventional therapy, abnormal mitochondrial morphology on kidney biopsy, involvement of other organs (e.g. diabetes, cardiomyopathy, and deafness) and a maternal family history, although none of these features are specific. The diagnostic approach involves acquiring tissue (typically skeletal muscle) for histological analysis, mtDNA screening and oxidative phosphorylation (OXPHOS) complex function tests. A number of nDNA mutations causing mitochondrial disease have now been identified and can also be screened for if clinically indicated. Management of mitochondrial disease requires a multidisciplinary approach, and treatment is largely supportive as there are currently very few evidence-based interventions. Electrolyte deficiencies should be corrected in patients with urinary wasting due to tubulopathy, and CoQ10 supplementation may be of benefit in individuals with CoQ10 deficiency. Nephrotic syndrome in mitochondrial disease is not typically responsive to steroid therapy. Transplantation has been performed in patients with end-stage kidney disease; however, immunosuppressive agents such as steroids and tacrolimus should be used with care given the high incidence of diabetes in mitochondrial disease.

Style APA, Harvard, Vancouver, ISO itp.

50

Sciarretta, Sebastiano, Richard N. Kitsis i Junichi Sadoshima, red. Mitochondrial Dysfunction and Cardiovascular Diseases. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-556-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!